PDCD1 and hepatocellular carcinoma: Similarly, another study found that in patients with unresectable recurrent HCC meeting the up-to-7 criteria, the median PFS was markedly longer in the TACE+LEN+PD-1 group (24.1 months) compared to the TACE+LEN group (17.3 months, P< 0.001) (24).